Atrium Therapeutics, Inc. (RNA) Spin-Off

Regulation FD Disclosure. Atrium Therapeutics, Inc., a Delaware corporation (the “Company”), previously filed with the Securities and Exchange Commission (“SEC”) a registration statement on Form 10, as amended (the “Registration Statement”), relating to the pro rata distribution (the “Distributio…